cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.20455163
title: Faunistic and ecological assessment of interstitial Harpacticoida (Crustacea, Copepoda) on a sandy beach in Balıkesir (Turkey)

description: Abstract Interstitial harpacticoids along the mediolittoral zones of Sarımsaklı Beach, Turkey, were sampled monthly between April 2016 and March 2017 in order to reveal the effects of pH, water temperature, salinity, electrical conductivity, dissolved oxygen, and grain size on the occurrence and composition of the harpacticoids. Examination of the samples from nine stations revealed a total of 66 species. In terms of harpacticoid species abundance, Ectinosoma soyeri Apostolov, 1975 was ranked first followed by Sarsamphiascus angustipes (Gurney, 1927) and Leptomesochra eulitoralis Noodt, 1952. The variations in harpacticoid community were estimated by using some ecological indices (Species richness, Shannon’s diversity and Pielou’s evenness). Principal component analysis (PCA) based on the abiotic factors was applied for ordination of the stations. Relationships between environmental and temporal parameters as well as harpacticoid community structure were analyzed using distance-based Linear Models (DistLM). Relationships between environmental variables and most abundant species were determined with the Redundancy analysis (RDA). The abundance of S. angustipes and Klieonychocamptus ponticus (Serban and Plesa, 1957) were positively correlated with all tested variables except water temperature. The abundance of Klieonychocamptus kliei (Monard, 1935) was positively correlated with water temperature, grain size and salinity, while it was negatively correlated with dissolved oxygen and pH. The abundance of Ameira sp. and Microsetella norvegica (Boeck, 1865) were negatively correlated with all tested variables except water temperature. The abundance of E. soyeri and Ameira parvula (Claus, 1866) were negatively correlated with all tested variables except pH. The abundance of Leptomesochra eulitoralis was positively correlated with water temperature and salinity, while it was negatively correlated with grain size, dissolved oxygen and pH.
DOI: 10.6084/m9.figshare.20455163.v1
title: Faunistic and ecological assessment of interstitial Harpacticoida (Crustacea, Copepoda) on a sandy beach in Balıkesir (Turkey)

description: Abstract Interstitial harpacticoids along the mediolittoral zones of Sarımsaklı Beach, Turkey, were sampled monthly between April 2016 and March 2017 in order to reveal the effects of pH, water temperature, salinity, electrical conductivity, dissolved oxygen, and grain size on the occurrence and composition of the harpacticoids. Examination of the samples from nine stations revealed a total of 66 species. In terms of harpacticoid species abundance, Ectinosoma soyeri Apostolov, 1975 was ranked first followed by Sarsamphiascus angustipes (Gurney, 1927) and Leptomesochra eulitoralis Noodt, 1952. The variations in harpacticoid community were estimated by using some ecological indices (Species richness, Shannon’s diversity and Pielou’s evenness). Principal component analysis (PCA) based on the abiotic factors was applied for ordination of the stations. Relationships between environmental and temporal parameters as well as harpacticoid community structure were analyzed using distance-based Linear Models (DistLM). Relationships between environmental variables and most abundant species were determined with the Redundancy analysis (RDA). The abundance of S. angustipes and Klieonychocamptus ponticus (Serban and Plesa, 1957) were positively correlated with all tested variables except water temperature. The abundance of Klieonychocamptus kliei (Monard, 1935) was positively correlated with water temperature, grain size and salinity, while it was negatively correlated with dissolved oxygen and pH. The abundance of Ameira sp. and Microsetella norvegica (Boeck, 1865) were negatively correlated with all tested variables except water temperature. The abundance of E. soyeri and Ameira parvula (Claus, 1866) were negatively correlated with all tested variables except pH. The abundance of Leptomesochra eulitoralis was positively correlated with water temperature and salinity, while it was negatively correlated with grain size, dissolved oxygen and pH.
DOI: 10.6084/m9.figshare.20455088
title: A new species of Tortanus (Atortus) Ohtsuka, 1992 (Copepoda, Calanoida, Tortanidae) from Great Nicobar Island, north-eastern Indian Ocean

description: Abstract A new planktonic copepod assigned to the subgenus Tortanus (Atortus) Ohtsuka, 1992 is described from Great Nicobar Island, Andaman and Nicobar archipelago. The new species Tortanus (Atortus) dhritiae sp. nov. belongs to the tropicus-group. The new species can be distinguished from all other species of the tropicus-group by the presence of a notch on the left lateral joining of fourth and fifth pedigerous somites, asymmetrical caudal rami with a rounded process originating from the anterior portion of the left ramus produced over to the right, and an elliptical shaped exopodal lobe of leg 5 with distolateral curved seta in female. In male, serrated ridge on the anterior one-third surface of segment XX of the right antennule, obtuse trapezoid-shaped right leg 5 coxa with triangle-shaped medial process, semi-circular basis with slight curve near base and crocodilian head-shaped medial process with small process distally and bearing one distal and one medial setae.
DOI: 10.6084/m9.figshare.20455088.v1
title: A new species of Tortanus (Atortus) Ohtsuka, 1992 (Copepoda, Calanoida, Tortanidae) from Great Nicobar Island, north-eastern Indian Ocean

description: Abstract A new planktonic copepod assigned to the subgenus Tortanus (Atortus) Ohtsuka, 1992 is described from Great Nicobar Island, Andaman and Nicobar archipelago. The new species Tortanus (Atortus) dhritiae sp. nov. belongs to the tropicus-group. The new species can be distinguished from all other species of the tropicus-group by the presence of a notch on the left lateral joining of fourth and fifth pedigerous somites, asymmetrical caudal rami with a rounded process originating from the anterior portion of the left ramus produced over to the right, and an elliptical shaped exopodal lobe of leg 5 with distolateral curved seta in female. In male, serrated ridge on the anterior one-third surface of segment XX of the right antennule, obtuse trapezoid-shaped right leg 5 coxa with triangle-shaped medial process, semi-circular basis with slight curve near base and crocodilian head-shaped medial process with small process distally and bearing one distal and one medial setae.
DOI: 10.6084/m9.figshare.20522945
title: Firm adjustment, employment and sub-contracting

description: ABSTRACT his article analyses the impact of sub-contracting on the labor market and the inefficiency that may result from it. Sub-contracting is partially associated with the increase in services employment and the decrease in manufacturing employment in the early 1990s. Thus, sub-contracting may decrease job quality and incentives to human capital accumulation, since services tend to value human capital less than manufacturing and have more informal and unstable labor relations. This scenario may deteriorate if the sub-contracted firms face credit constraints. Due to the existence of externalities, investment in human capital would be sub-optimal even if contracting firms were willing to invest in the sub-contracted ones.
DOI: 10.6084/m9.figshare.20522945.v1
title: Firm adjustment, employment and sub-contracting

description: ABSTRACT his article analyses the impact of sub-contracting on the labor market and the inefficiency that may result from it. Sub-contracting is partially associated with the increase in services employment and the decrease in manufacturing employment in the early 1990s. Thus, sub-contracting may decrease job quality and incentives to human capital accumulation, since services tend to value human capital less than manufacturing and have more informal and unstable labor relations. This scenario may deteriorate if the sub-contracted firms face credit constraints. Due to the existence of externalities, investment in human capital would be sub-optimal even if contracting firms were willing to invest in the sub-contracted ones.
DOI: 10.6084/m9.figshare.20522946
title: Production time and container size for Simarouba amara Aubl. seedlings

description: Abstract This study aims to determine the effect of nursery production time and container size on the quality standards of production of Simarouba amara seedlings based on nursery and field performance. The work was conducted in two phases: evaluation of nursery growth and field performance. A completely randomized design was used in both phases. Three container sizes (55, 180 and 280cm³) and four nursery production times (105, 125, 135 and 145 days) were tested. Height, collar diameter and survival were evaluated. S. amara seedlings can be produced in a 180 cm³ container with a maximum nursery production time of 125 days. The quality standard for seedlings corresponds to collar diameter ≥ 4.2 and height ≥ 9.1 cm.
DOI: 10.6084/m9.figshare.20522946.v1
title: Production time and container size for Simarouba amara Aubl. seedlings

description: Abstract This study aims to determine the effect of nursery production time and container size on the quality standards of production of Simarouba amara seedlings based on nursery and field performance. The work was conducted in two phases: evaluation of nursery growth and field performance. A completely randomized design was used in both phases. Three container sizes (55, 180 and 280cm³) and four nursery production times (105, 125, 135 and 145 days) were tested. Height, collar diameter and survival were evaluated. S. amara seedlings can be produced in a 180 cm³ container with a maximum nursery production time of 125 days. The quality standard for seedlings corresponds to collar diameter ≥ 4.2 and height ≥ 9.1 cm.
DOI: 10.6084/m9.figshare.20484462
title: Deep brain stimulation in Parkinson’s disease: state of the art and future perspectives

description: ABSTRACT For more than 30 years, Deep Brain Stimulation (DBS) has been a therapeutic option for Parkinson’s disease (PD) treatment. However, this therapy is still underutilized mainly due to misinformation regarding risks and clinical outcomes. DBS can ameliorate several motor and non-motor symptoms, improving patients’ quality of life. Furthermore, most of the improvement after DBS is long-lasting and present even in advanced PD. Adequate patient selection, precise electric leads placement, and correct DBS programming are paramount for good surgical outcomes. Nonetheless, DBS still has many limitations: axial symptoms and signs, such as speech, balance and gait, do not improve to the same extent as appendicular symptoms and can even be worsened as a direct or indirect consequence of surgery and stimulation. In addition, there are still unanswered questions regarding patient’s selection, surgical planning and programming techniques, such as the role of surgicogenomics, more precise imaging-based lead placement, new brain targets, advanced programming strategies and hardware features. The net effect of these innovations should not only be to refine the beneficial effect we currently observe on selected symptoms and signs but also to improve treatment resistant facets of PD, such as axial and non-motor features. In this review, we discuss the current state of the art regarding DBS selection, implant, and programming, and explore new advances in the DBS field.
DOI: 10.6084/m9.figshare.20484462.v1
title: Deep brain stimulation in Parkinson’s disease: state of the art and future perspectives

description: ABSTRACT For more than 30 years, Deep Brain Stimulation (DBS) has been a therapeutic option for Parkinson’s disease (PD) treatment. However, this therapy is still underutilized mainly due to misinformation regarding risks and clinical outcomes. DBS can ameliorate several motor and non-motor symptoms, improving patients’ quality of life. Furthermore, most of the improvement after DBS is long-lasting and present even in advanced PD. Adequate patient selection, precise electric leads placement, and correct DBS programming are paramount for good surgical outcomes. Nonetheless, DBS still has many limitations: axial symptoms and signs, such as speech, balance and gait, do not improve to the same extent as appendicular symptoms and can even be worsened as a direct or indirect consequence of surgery and stimulation. In addition, there are still unanswered questions regarding patient’s selection, surgical planning and programming techniques, such as the role of surgicogenomics, more precise imaging-based lead placement, new brain targets, advanced programming strategies and hardware features. The net effect of these innovations should not only be to refine the beneficial effect we currently observe on selected symptoms and signs but also to improve treatment resistant facets of PD, such as axial and non-motor features. In this review, we discuss the current state of the art regarding DBS selection, implant, and programming, and explore new advances in the DBS field.
DOI: 10.6084/m9.figshare.20484540.v1
title: Anticoagulation and Stroke

description: Abstract In 2019, the American Heart Association did not recommend the emergent use of anticoagulation to prevent recurrence or progression of acute ischemic stroke. However, its indication in patients with extracranial artery intraluminal thrombus with artery-to-artery cerebral embolization must be analyzed. In this article, we will also discuss other indications of anticoagulation. This treatment could be indicated in patients with ischemic stroke caused by embolization from cervical artery dissection, catastrophic antiphospholipid antibodies syndrome (APS) and some cases of Covid 19. For secondary prevention, anticoagulation is recommended for Cardioembolic stroke such as nonvalvular atrial fibrillation and other cardiopathies, some patients with cervical artery dissection, stroke associated with cancer, and thrombophilia such as APS. The timing to restart anticoagulation after a large ischemic stroke or after a cerebral hemorrhagic transformation always represent a challenge. Even in patients with high risk of thromboembolism it should be delayed at least two weeks, ideal after four weeks.
DOI: 10.6084/m9.figshare.20522948
title: HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease

description: Abstract Background Children and adolescents with congenital heart disease may be more likely to develop atherogenic cardiovascular diseases in adulthood. Therefore, the early identification of risk factors and intervention in childhood may be crucial for a good quality of life and longevity. Objectives To describe the distribution of high-density lipoprotein-cholesterol (HDL-c) levels and its association with socioeconomic, clinical and cardiovascular risk factors in children and adolescents with congenital heart disease. Methods Cross-sectional study with children and adolescents aged between 5 and 18 years, with congenital heart disease. Socioeconomic, clinical and cardiovascular risk factors were evaluated. HDL-c concentrations were evaluated by the direct method and categorized as desirable (&gt;45 mg/dL), borderline (40-45 mg/dL) and low (&lt;40 mg/dL). We also assessed the “undesirable” levels, consisting of the sum of “borderline” and “low” values for comparative purposes. The multivariate logistic regression analysis was used to evaluate the factor associated with undesirable HDL-c levels. A p&lt;0.05 value was adopted as statistically significant. Results Mean HDL-c was 51.2 mg/dL (SD 12.6), with a prevalence of 33.2% of undesirable HDL-c. In the multivariate analysis, C-reactive protein levels ≥ 3mg/dL (OR 3.26; 95% CI 1.32-8.04), age ≥ 10 years old (OR: 2.11; 95% CI 1.12-3.99) and undesirable levels of triglycerides (OR 2.21; 95% CI 1.13-4.75) were associated with undesirable HDL-c. Conclusion In this sample of children and adolescents with congenital heart disease, almost one third presented low or borderline HDL-c levels. Age ≥10 years, C-reactive protein and triglycerides were associated with undesirable HDL-c levels. These factors should be considered in the prevention of cerebrovascular diseases in adulthood in this population.
DOI: 10.6084/m9.figshare.20522948.v1
title: HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease

description: Abstract Background Children and adolescents with congenital heart disease may be more likely to develop atherogenic cardiovascular diseases in adulthood. Therefore, the early identification of risk factors and intervention in childhood may be crucial for a good quality of life and longevity. Objectives To describe the distribution of high-density lipoprotein-cholesterol (HDL-c) levels and its association with socioeconomic, clinical and cardiovascular risk factors in children and adolescents with congenital heart disease. Methods Cross-sectional study with children and adolescents aged between 5 and 18 years, with congenital heart disease. Socioeconomic, clinical and cardiovascular risk factors were evaluated. HDL-c concentrations were evaluated by the direct method and categorized as desirable (&gt;45 mg/dL), borderline (40-45 mg/dL) and low (&lt;40 mg/dL). We also assessed the “undesirable” levels, consisting of the sum of “borderline” and “low” values for comparative purposes. The multivariate logistic regression analysis was used to evaluate the factor associated with undesirable HDL-c levels. A p&lt;0.05 value was adopted as statistically significant. Results Mean HDL-c was 51.2 mg/dL (SD 12.6), with a prevalence of 33.2% of undesirable HDL-c. In the multivariate analysis, C-reactive protein levels ≥ 3mg/dL (OR 3.26; 95% CI 1.32-8.04), age ≥ 10 years old (OR: 2.11; 95% CI 1.12-3.99) and undesirable levels of triglycerides (OR 2.21; 95% CI 1.13-4.75) were associated with undesirable HDL-c. Conclusion In this sample of children and adolescents with congenital heart disease, almost one third presented low or borderline HDL-c levels. Age ≥10 years, C-reactive protein and triglycerides were associated with undesirable HDL-c levels. These factors should be considered in the prevention of cerebrovascular diseases in adulthood in this population.
DOI: 10.6084/m9.figshare.20484540
title: Anticoagulation and Stroke

description: Abstract In 2019, the American Heart Association did not recommend the emergent use of anticoagulation to prevent recurrence or progression of acute ischemic stroke. However, its indication in patients with extracranial artery intraluminal thrombus with artery-to-artery cerebral embolization must be analyzed. In this article, we will also discuss other indications of anticoagulation. This treatment could be indicated in patients with ischemic stroke caused by embolization from cervical artery dissection, catastrophic antiphospholipid antibodies syndrome (APS) and some cases of Covid 19. For secondary prevention, anticoagulation is recommended for Cardioembolic stroke such as nonvalvular atrial fibrillation and other cardiopathies, some patients with cervical artery dissection, stroke associated with cancer, and thrombophilia such as APS. The timing to restart anticoagulation after a large ischemic stroke or after a cerebral hemorrhagic transformation always represent a challenge. Even in patients with high risk of thromboembolism it should be delayed at least two weeks, ideal after four weeks.
DOI: 10.6084/m9.figshare.20484516
title: Atherosclerosis risk factor management - what's new for the neurologist?

description: ABSTRACT Stroke is the second leading cause of death worldwide and the vast majority can be attributed to modifiable risk factors, mainly behavioral and metabolic. The top six risk factors responsible for cardiovascular mortality in Brazil in 2019 were high systolic blood pressure, inadequate dietary exposure, high body mass index, high LDL cholesterol, high fasting blood glucose levels, and tobacco. We intend to discuss in this paper the evidence and recommendations in the approach of three essential risk factors for patients with a history of stroke: dyslipidemia, hypertension and diabetes.
DOI: 10.6084/m9.figshare.20484516.v1
title: Atherosclerosis risk factor management - what's new for the neurologist?

description: ABSTRACT Stroke is the second leading cause of death worldwide and the vast majority can be attributed to modifiable risk factors, mainly behavioral and metabolic. The top six risk factors responsible for cardiovascular mortality in Brazil in 2019 were high systolic blood pressure, inadequate dietary exposure, high body mass index, high LDL cholesterol, high fasting blood glucose levels, and tobacco. We intend to discuss in this paper the evidence and recommendations in the approach of three essential risk factors for patients with a history of stroke: dyslipidemia, hypertension and diabetes.
DOI: 10.6084/m9.figshare.20484519
title: A critical review and update on autoimmune encephalitis: understanding the alphabet soup

description: ABSTRACT Autoimmune encephalitis (AE) comprises a group of diseases mediated by antibodies against neuronal cell surface or synaptic antigens, such as ion channels or neurotransmitter receptors. New clinical syndromes and their associated antibodies were and are still being characterized over the last two decades. The fact that their main clinical features are interdisciplinary, - encompassing neuropsychiatric symptoms, cognitive dysfunction, epileptic seizures, movement and sleep disorders - has led to a surge of interest in this field. Some of these diseases present with a well-defined syndrome, being recognizable on clinical grounds. Correct diagnosis is important since AE are potentially treatable diseases, despite their severity. On the other hand, an increasing number of neuronal antibodies being described casts doubt upon the way we should utilize antibody testing and interpret results. In this article we review, summarize and update the current knowledge on antibody mediated encephalitis.
DOI: 10.6084/m9.figshare.20484519.v1
title: A critical review and update on autoimmune encephalitis: understanding the alphabet soup

description: ABSTRACT Autoimmune encephalitis (AE) comprises a group of diseases mediated by antibodies against neuronal cell surface or synaptic antigens, such as ion channels or neurotransmitter receptors. New clinical syndromes and their associated antibodies were and are still being characterized over the last two decades. The fact that their main clinical features are interdisciplinary, - encompassing neuropsychiatric symptoms, cognitive dysfunction, epileptic seizures, movement and sleep disorders - has led to a surge of interest in this field. Some of these diseases present with a well-defined syndrome, being recognizable on clinical grounds. Correct diagnosis is important since AE are potentially treatable diseases, despite their severity. On the other hand, an increasing number of neuronal antibodies being described casts doubt upon the way we should utilize antibody testing and interpret results. In this article we review, summarize and update the current knowledge on antibody mediated encephalitis.